<DOC>
	<DOCNO>NCT02475642</DOCNO>
	<brief_summary>The purpose study compare efficacy safety PV isolation continue antiarrhythmic drug treatment ( PVI+ADT ) PV isolation without continue ADT ( PVI-ADT ) patient undergo treatment symptomatic recurrent AF .</brief_summary>
	<brief_title>Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment Subjects With Recurrent Atrial Fibrillation</brief_title>
	<detailed_description>Subjects underwent PV isolation paroxysmal non-longstanding persistent AF free arrhythmia end 3-month blanking period take ADT . Eligible subject sign study inform consent form randomize one two study arm : PVI+ADT Group : continue ADT 9 month follow-up PVI-ADT Group : ADT 9 month follow</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>patient continue ( IC III ) ADT throughout 3month blank patient free symptomatic asymptomatic AF ( evidence 1day Holter ) 3month visit drugresistant ( least one class IC III ) symptomatic AF primary indication prior PV isolation three month prior PVI , least one episode symptomatic asymptomatic AF PV isolation perform accord standard set forward Task Force Document ( sedation general anesthesia ) PV isolation target ablation ( except cavotricuspid ( CTI ) ablation document AFL ) PV isolation perform pointbypoint irrigate radio frequency ( RF ) guide contactforce ( Biosense ) ( 1030grcontinuous lesion ) PV isolation ( i.e . entry block ) verify vein wait time adenosine ( continued RF acute reconnection ) Signed Patient Informed Consent Form . Age 18 year old . Able willing comply followup test requirement . Longstanding persistent atrial fibrillation ( &gt; 12 month continuous AF ) Previous ablation AF leave atrium ( LA ) size &gt; 55 mm leave ventricular ejection fraction ( LVEF ) &lt; 40 % AF secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause coronary artery bypass graft ( CABG ) procedure within last six month Awaiting cardiac transplantation cardiac surgery Documented leave atrial thrombus image Diagnosed atrial myxoma Women pregnant ( history menstrual period pregnancy test history consider unreliable ) breastfeed Acute illness active systemic infection sepsis Unstable angina Uncontrolled heart failure Myocardial infarction within previous two ( 2 ) month History blood clot bleed abnormality Contraindication anticoagulation therapy ( ie , heparin warfarin ) Life expectancy le 12 month Enrollment study evaluate another device drug Presence intramural thrombus , tumor abnormality precludes catheter introduction Patients take class IC III ADT 3 month PV isolation No documentation entry block initial PV isolation wait time adenosine . Additional linear ablation defractionation initial procedure ( except CTI ablation document induced cavotricuspid isthmus dependent flutter ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>